. . . .
Teva Pharmaceutical (TEVA): A Dividend Contender with 13 Consecutive Years of Dividend Increases
Since dividends are paid out of earnings, a clear perspective of a company’s historical earnings growth record is a vital component of a dividend investor’s prudent due diligence process. The following graph plots Teva Pharmaceutical’s earnings per share since 1998. A quick glance to the right of the graph shows that Teva Pharmaceutical has increased earnings at a compounded rate of 23.1% (see purple circle on graph) per annum.
. . . .
